Home/Filings/4/0001724521-23-000024
4//SEC Filing

Azoy Alexander 4

Accession 0001724521-23-000024

CIK 0001724521other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:28 PM ET

Size

4.8 KB

Accession

0001724521-23-000024

Insider Transaction Report

Form 4
Period: 2023-12-01
Azoy Alexander
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2023-12-01$14.95/sh282$4,21611,596 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2023.
  • [F2]Consists of 282 shares purchased on 11/30/2023 through the Company's Employee Stock Purchase Plan.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001771961

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:28 PM ET
Size
4.8 KB